Health Catalyst Reports Fourth Quarter and Year End 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Health Catalyst (HCAT) Tops Q4 EPS by 8c, Revenues Beat; Offers Q1 & FY20 Revenue Guidance
February 27, 2020 5:01 PM ESTHealth Catalyst (NASDAQ: HCAT) reported Q4 EPS of ($0.21), $0.08 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $43.5 million versus the consensus estimate of $41.71 million.
We concluded an exceptional year for Health Catalyst on a high note in the fourth quarter of 2019, achieving strong results across all... More
